Chuck Triano | SVP of IR |
Albert Bourla | CEO and Chairman |
Frank D'Amelio | CFO |
Mikael Dolsten | President of Worldwide Research and Development |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
Randall Stanicky | RBC Capital Markets |
Chris Schott | JP Morgan |
Terence Flynn | Goldman Sachs |
Umer Raffat | Evercore ISI |
David Risinger | Morgan Stanley |
Louise Chen | Cantor Fitzgerald |
Steve Scala | Cowen |
Geoff Meacham | Bank of America |
Tim Anderson | Wolfe Research |
Andrew Baum | Citi |
Navin Jacob | UBS |
Mani Foroohar | SVB Leerink |
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2019 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.